TOP TIERMARKET NEWSWIRE
News & sentiment

APTEVO THERAPEUTICS (APVO) — News & AI sentiment

APTEVO THERAPEUTICS (APVO) news roundup. 10 stories aggregated over the last 30 days. Average 30-day sentiment is 49.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
10
avg sentiment 49.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

APVO news in the last 24 hours, 7 days, 30 days and 90 days

How much APVO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAPVO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1049.9/100APVO headlines →
Last 90 days1949.1/100APVO headlines →

Latest stories on APVO

Sep 3
Why is Aptevo Therapeutics stock slumping today?
Investing.com Markets34 · bearishgeneral
Sep 3
Sep 3
Sep 3
Sep 3
Aug 21
Aug 21
Aug 17
Aug 16
Aug 14
Aptevo Therapeutics reports Q2 results
Seeking Alpha50 · neutralearnings
Aug 14
Aug 14
Aug 13
Aug 13
Aug 12
Jul 27
Jul 27
Jun 30
Jun 30
May 28
May 27
May 27
Open APVO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →